Collaborative Approach
When it comes to partnering, Pfizer brings a mix of transparency and flexibility to each deal to ensure successful interactions over the long term. As our partner, you'll be part of a team that works together to turn today's discoveries into tomorrow's breakthroughs.
We believe in building trust from our very first interactions—regardless of the size of the deal. Experienced alliance managers will work with your team every step of the way, with open communication at all levels to ensure the application of appropriate resources. Our combined talent and expertise is brought to bear in order to ensure that effective governance and shared decision making is applied to each allied development program.
Adolor can say that, from the people with whom we have been working on a day-to-day basis, to the very top of the Company, we have been nothing short of overwhelmed with the energy that has gone into putting this collaboration together, and believe that Pfizer is highly motivated to present themselves as a partner of choice.![]()
—Kevin Taylor, Vice President of Business Development, Adolor Corporation
"Pfizer is committed to flexible, transparent and mutually beneficial long-term relationships with its partners. By joining forces, we can bring quality therapies to patients worldwide. Let's work together for a healthier world."

The Adolor/Pfizer collaboration has the fundamental building blocks of a solid, mutually beneficial alliance. In any collaboration, organizational differences—combined with the day-to-day challenges of drug development—make for a potentially challenging relationship. However, both Adolor and Pfizer have worked hard from the start to ensure that honest discussion and shared decision making is at the core of their work. Through the development of joint steering committees, team-building exercises, face-to-face meetings, and clearly defined roles and responsibilities, they've formed a strong collaboration that will continue to strengthen even further over time.


